4.6 Article

Gray and white matter imaging: A biomarker for cognitive impairment in early Parkinson's disease?

Related references

Note: Only part of the references are listed.
Article Geriatrics & Gerontology

The incidence of Parkinson's disease in the North-East of England

Gordon William Duncan et al.

AGE AND AGEING (2014)

Article Clinical Neurology

Cognitive deficits in mild Parkinson's disease are associated with distinct areas of grey matter atrophy

Elijah Mak et al.

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2014)

Article Neurosciences

The Topography of Brain Damage at Different Stages of Parkinson's Disease

Federica Agosta et al.

HUMAN BRAIN MAPPING (2013)

Article Clinical Neurology

The CamPaIGN study of Parkinson's disease: 10-year outlook in an incident population-based cohort

Caroline H. Williams-Gray et al.

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2013)

Article Clinical Neurology

Evolution of mild cognitive impairment in Parkinson disease

M. Broeders et al.

NEUROLOGY (2013)

Article Multidisciplinary Sciences

Pattern of Regional Cortical Thinning Associated with Cognitive Deterioration in Parkinson's Disease

Javier Pagonabarraga et al.

PLOS ONE (2013)

Article Clinical Neurology

Prognosis of Mild Cognitive Impairment in Early Parkinson Disease

Kenn Freddy Pedersen et al.

JAMA NEUROLOGY (2013)

Article Neurosciences

Cognitive status correlates with white matter alteration in Parkinson's disease

Takaaki Hattori et al.

HUMAN BRAIN MAPPING (2012)

Article Clinical Neurology

Grey matter atrophy in cognitively impaired Parkinson's disease

Tracy R. Melzer et al.

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2012)

Article Clinical Neurology

Neurodegeneration Across Stages of Cognitive Decline in Parkinson Disease

Daniel Weintraub et al.

ARCHIVES OF NEUROLOGY (2011)

Article Clinical Neurology

Gray Matter Correlations of Cognition in Incident Parkinson's Disease

Turi O. Dalaker et al.

MOVEMENT DISORDERS (2010)

Review Clinical Neurology

Systematic Review of Levodopa Dose Equivalency Reporting in Parkinson's Disease

Claire L. Tomlinson et al.

MOVEMENT DISORDERS (2010)

Article Neurosciences

Structural brain correlates of verbal fluency in Parkinson's disease

Joana B. Pereira et al.

NEUROREPORT (2009)

Article Neurosciences

A fast diffeomorphic image registration algorithm

John Ashburner

NEUROIMAGE (2007)

Article Clinical Neurology

Dementia in Parkinson's disease: diffusion tensor imaging

H. Matsui et al.

ACTA NEUROLOGICA SCANDINAVICA (2007)

Article Clinical Neurology

Evolution of cognitive dysfunction in an incident Parkinson's disease cohort

C. H. Williams-Gray et al.

BRAIN (2007)

Article Clinical Neurology

Cognitive profile of patients with newly diagnosed Parkinson disease

D Muslimovic et al.

NEUROLOGY (2005)

Article Geriatrics & Gerontology

The montreal cognitive assessment, MoCA:: A brief screening tool for mild cognitive impairment

ZS Nasreddine et al.

JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2005)

Review Clinical Neurology

Cerebral atrophy and its relation to cognitive impairment in Parkinson disease

A Nagano-Saito et al.

NEUROLOGY (2005)

Review Clinical Neurology

Verbal fluency deficits in Parkinson's disease: A meta-analysis

JD Henry et al.

JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY (2004)

Article Radiology, Nuclear Medicine & Medical Imaging

Correction of high-order eddy current induced geometric distortion in diffusion-weighted echo-planar images

YJ Shen et al.

MAGNETIC RESONANCE IN MEDICINE (2004)

Review Cell Biology

Stages in the development of Parkinson's disease-related pathology

H Braak et al.

CELL AND TISSUE RESEARCH (2004)

Article Neurosciences

Voxel-based morphometry - The methods

J Ashburner et al.

NEUROIMAGE (2000)

Review Ophthalmology

Macular microcirculation characteristics in Parkinson's disease evaluated by OCT-Angiography: a literature review

Evita Evangelia Christou et al.

Summary: The retina may serve as a predictive factor for neurodegenerative disorders, with recent use of Optical Coherence Tomography Angiography (OCT-A) in studying macular microcirculation changes in Parkinson's disease (PD). While preliminary evidence suggests OCT-A could be a useful biomarker for cerebral vasculature in PD, further research is needed to confirm its predictive value in clinical practice.

SEMINARS IN OPHTHALMOLOGY